Target- |
Mechanism- |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date08 Jun 1964 |
100 Clinical Results associated with Hubei Kelun Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Hubei Kelun Pharmaceutical Co., Ltd.
100 Deals associated with Hubei Kelun Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Hubei Kelun Pharmaceutical Co., Ltd.